Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Allena Pharmaceuticals, Inc. (ALNA) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Allena Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1624658.
Total stock buying since 2017: $21,523,992.
Total stock sales since 2017: $294,118.
Total stock option exercises since 2017: $39,750.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 0 | $0 | 65,543 | $60,653 | 209,303 | $0 |
| 2020 | 0 | $0 | 171,666 | $233,465 | 412,754 | $0 |
| 2018 | 0 | $0 | 0 | $0 | 25,000 | $39,750 |
| 2017 | 1,537,428 | $21,523,992 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-11 | 0 | $0 | 40,328 | $32,665 | 125,582 | $0 |
| 2021-05 | 0 | $0 | 25,215 | $27,988 | 83,721 | $0 |
| 2020-12 | 0 | $0 | 171,666 | $233,465 | 412,754 | $0 |
| 2018-05 | 0 | $0 | 0 | $0 | 25,000 | $39,750 |
| 2017-11 | 1,537,428 | $21,523,992 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-11-15 | Brenner Louis Md (President and CEO) | Sale | 40,328 | .81 | 32,665 |
| 2021-11-15 | Brenner Louis Md (President and CEO) | Option Ex | 125,582 | .00 | 0 |
| 2021-05-10 | Brenner Louis Md (President and COO) | Sale | 25,215 | 1.11 | 27,988 |
| 2021-05-10 | Brenner Louis Md (President and COO) | Option Ex | 83,721 | .00 | 0 |
| 2020-12-17 | Wholihan Edward (Chief Financial Officer) | Sale | 68,550 | 1.36 | 93,228 |
| 2020-12-17 | Wholihan Edward (Chief Financial Officer) | Option Ex | 164,822 | .00 | 0 |
| 2020-12-17 | Brenner Louis Md (President and CEO) | Sale | 103,116 | 1.36 | 140,237 |
| 2020-12-17 | Brenner Louis Md (President and CEO) | Option Ex | 247,932 | .00 | 0 |
| 2018-05-09 | Wholihan Edward (Chief Financial Officer) | Option Ex | 25,000 | 1.59 | 39,750 |
| 2017-11-06 | Hbm Biocapital Ii Lp | Buy | 71,428 | 14.00 | 999,992 |
| 2017-11-06 | Frazier Healthcare Vi, L.p. (10% Owner) | Buy | 500,000 | 14.00 | 7,000,000 |
| 2017-11-06 | Bessemer Venture Partners Vii Institutional L.p. (10% Owner) | Buy | 36,000 | 14.00 | 504,000 |
| 2017-11-06 | Topper James N (Director) | Buy | 500,000 | 14.00 | 7,000,000 |
| 2017-11-06 | Starr Kevin P (10% Owner) | Buy | 215,000 | 14.00 | 3,010,000 |
| 2017-11-06 | Tepper Robert I (Director) | Buy | 215,000 | 14.00 | 3,010,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of ALNA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Allena Pharmaceuticals, Inc. (symbol ALNA, CIK number 1624658) see the Securities and Exchange Commission (SEC) website.